Constructive Bio
PrivateLast Round
Series A
Extension
Mar 27, 2025
Total Funding Raised
$74.48M
Company Overview
Constructive Bio is a biotechnology company that engineers synthetic genomes and cellular machinery to transform living cells into biofactories for the production of enzymes, pharmaceuticals, and biomaterials.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Constructive Bio Comparables
Compare Constructive Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ribbon Bio | 79% | |
| Camena Bioscience | 77% | |
| Pearl Bio | 74% |
Constructive Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Mar 27, 2025 | ||||
| Grant | Mar 5, 2025 | ||||
| Series A | Sep 24, 2024 | ||||
| Seed | Aug 15, 2022 |
Key People
Founding team and executive leadership
Constructive Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Amadeus Capital Partners | Seed |
| Fine Structure Ventures | Series A |
| OMX Ventures | Seed, Series A |
| F-Prime Capital | Series A |
| UKRI Innovate UK | Grant |
| +ND Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 11, 2026
Monthly visitors grew 42% MoM, reaching 4.6K.
- Oct 10, 2025
Partnered with the Ellison Institute of Technology and its Generative Biology Institute.
Constructive Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Constructive Bio's valuation, stock price, and market status.
Is Constructive Bio a public or private company?
Constructive Bio is a private company.
What is the current stock price of Constructive Bio?
Constructive Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Constructive Bio worth (valuation)?
Valuation information for Constructive Bio is not publicly available.
Can I buy Constructive Bio stock?
Constructive Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Constructive Bio's last funding round?
Constructive Bio's most recent funding round was Series A Extension on March 27, 2025.
Who are the main investors in Constructive Bio?
Key investors in Constructive Bio include Paladin Capital Group, Ahren Innovation Capital.
Will Constructive Bio IPO soon?
No public IPO plans have been announced for Constructive Bio.
How can I track Constructive Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Constructive Bio's secondary market activity and sign up for updates.